Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,893.00
Bid: 1,892.00
Ask: 1,893.00
Change: -24.00 (-1.25%)
Spread: 1.00 (0.053%)
Open: 1,921.00
High: 1,921.00
Low: 1,881.00
Prev. Close: 1,917.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE 100 on track for fourth straight loss

Wed, 17th Apr 2013 11:39

A number of heavyweight stocks going ex-dividend assured that London's FTSE 100 index was in the red for a fourth consecutive day on Wednesday, while concerns over the global economy continued to weigh on sentiment.Global growth fears have hit markets over the last few days after a surprise slowdown was reported in China in the first quarter. These concerns were compounded yesterday when the International Monetary Fund (IMF) revised lower its forecasts for global economic growth, cutting estimates for the UK, US, Eurozone and China.Unconfirmed rumours of a German credit rating downgrade were also giving investors more reasons to be cautious this morning, as well as the UK unemployment rate rising from 7.8% to 7.9% in the three months to February.The minutes from the latest Bank of England's Monetary Policy Committee (MPC) meeting released today showed that policymakers were split six to three in favour of maintaining the asset purchase programme at £375bn, as expected. They voted unanimously to keep the Bank Rate at 0.5%.For Barclays Research, today's minutes confirm its view that the redrafted MPC remit included in the March Budget does not give the committee greater leeway to focus on stimulating the economy. In that same vein, analysts point out that should activity stabilise, afterwards returning to growth while inflation stays high, then a majority of the MPC will not vote to increase quantitative easing (QE). However, they said that "it would take relatively little bad news on demand to propel the committee into a further QE push".US indices performed well last night after Goldman Sachs joined a growing list of companies to report better-than-expected earnings. Banking peers Citigroup, Wells Fargo and JPMorgan Chase have all beaten forecasts with their first-quarter results in the past week. Futures Stateside are pointing to a weak start ahead of earnings from Bank of America ahead of the opening bell.FTSE 100: Ex-div stocks provide a dragA number of heavyweight constituents went ex-dividend this morning, meaning that new investors will not be able to get their hands on the latest dividend payments. These companies included: ARM, BAE Systems, BG Group, Capita, Fresnillo, Petrofac, Resolution, Smith & Nephew, Tullow Oil and Wood Group.Iconic British luxury brand Burberry gained after reporting a 9.0% rise in underlying revenue in the second half as strong growth in Retail continued to offset a weaker performance in Wholesale.BHP Billiton, one of the world's largest miners, fell despite confirming that it was on track to hit full-year targets despite a lacklustre quarter.Tesco was also lower after posting its first decline in annual profits in two decades. The supermarket giant reported an underlying pre-tax profit of £3.5bn in the year to February 23rd 2013, a 10.7% fall from the £3.92bn the previous year.Financial services group Hargreaves Lansdown was making gains after saying that assets under administration reached record levels in the last three months as investor confidence continues to improve.FTSE 250: Hikma goes ex-div, decides not to sell injectablesHikma Pharmaceuticals was a heavy faller today after going ex-dividend, along with others including Chemring, Rentokil, Taylor Wimpey and Spirax-Sarco Engineering. Hikma also announced that it has decided not to sell its global injectables business despite significant interest.Hochschild Mining fell after reporting a fall in silver production and sales for the first quarter. Silver production came to 4.3m ounces in the three months to March 31st, down from 4.77m in the previous quarter and 4.76m a year earlier. Petra Diamond was heading the other way after discovering a 25.5 carat blue diamond at the Cullinan mine in South Africa. The rare stone is considered to be a high quality gem diamond of top colour. FTSE 100 - RisersBurberry Group (BRBY) 1,320.00p +4.27%Hargreaves Lansdown (HL.) 936.50p +4.06%ARM Holdings (ARM) 890.50p +2.59%Carnival (CCL) 2,291.00p +1.73%Centrica (CNA) 381.40p +1.36%Severn Trent (SVT) 1,759.00p +1.21%International Consolidated Airlines Group SA (CDI) (IAG) 252.40p +1.16%Diageo (DGE) 1,983.00p +1.15%Rolls-Royce Holdings (RR.) 1,127.00p +1.08%BT Group (BT.A) 277.20p +1.02%FTSE 100 - FallersFresnillo (FRES) 1,088.00p -6.29%Resolution Ltd. (RSL) 258.70p -6.27%Evraz (EVR) 157.30p -5.18%BAE Systems (BA.) 375.60p -3.72%Polymetal International (POLY) 719.50p -3.29%Petrofac Ltd. (PFC) 1,297.00p -3.21%Tesco (TSCO) 372.50p -3.21%BG Group (BG.) 1,047.00p -2.97%Prudential (PRU) 1,026.00p -2.56%Weir Group (WEIR) 2,158.00p -2.53%FTSE 250 - RisersSpirent Communications (SPT) 126.90p +3.34%Savills (SVS) 525.50p +2.64%Laird (LRD) 212.60p +2.46%Marston's (MARS) 135.30p +2.19%Synthomer (SYNT) 182.60p +2.18%St James's Place (STJ) 494.40p +1.79%Domino's Pizza Group (DOM) 622.50p +1.72%Rank Group (RNK) 157.60p +1.68%Hiscox Ltd. (HSX) 548.00p +1.67%Premier Farnell (PFL) 205.00p +1.49%FTSE 250 - FallersFerrexpo (FXPO) 163.50p -5.82%Hikma Pharmaceuticals (HIK) 935.00p -5.08%Perform Group (PER) 473.50p -4.61%SVG Capital (SVI) 369.40p -4.50%Lonmin (LMI) 263.10p -4.22%Beazley (BEZ) 204.80p -3.67%Kazakhmys (KAZ) 333.90p -3.41%BlackRock World Mining Trust (BRWM) 489.00p -2.88%SDL (SDL) 408.00p -2.83%Mondi (MNDI) 837.00p -2.73%BC
More News
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.